From a chemistry, manufacturing, and controls (CMC) perspective, ADCs present unique hurdles. “ADCs introduce unique challenges across areas like process and purification development, analytical ...

Lotte Biologics Co., the biotech arm of Lotte Group, said Wednesday it has signed a contract with a U.S.-based oncology ...

From payload optimization to integrated GMP manufacturing, companies aim to elevate oncology ADCs to standard of care.

Antibody discovery research paves the way for new therapeutics. The search for the right antibody for a specific therapeutic application necessitates several iterations of antibody production and ...

The key for optimizing cell-line development for antibody derivatives might just be to prioritize early assessment of product ...

Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and ...

Antibody-drug conjugates (ADCs) are at the forefront of cancer therapy, combining targeted precision with potent cytotoxicity. Conceived by Paul Ehrlich in the early 1900s, the concept of a magic ...

FDA fast tracked ZW191 for platinum-resistant ovarian cancer, aiming to speed development of a potential new option for patients with limited treatments. The U.S. Food and Drug Administration (FDA) ...

Waters Corporation today announced the launch of the BioResolve ™ Protein A Affinity Columns with MaxPeak ™ Premier Technology, providing precise titer measurements. This launch marks the first set of ...

Researchers from The University of Texas MD Anderson Cancer Center have developed a first-in-class antibody that targets a ...